Etoposide phosphate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1991 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 98 | 327 | 81 | 15 | 39 | 500 |
| Small cell lung carcinoma | D055752 | — | — | 57 | 190 | 71 | 4 | 28 | 316 |
| Lung neoplasms | D008175 | — | C34.90 | 62 | 156 | 62 | 4 | 23 | 273 |
| Leukemia | D007938 | — | C95 | 68 | 128 | 75 | 6 | 21 | 259 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 59 | 142 | 31 | 5 | 9 | 210 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 36 | 83 | 40 | 9 | 18 | 164 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 45 | 94 | 21 | 1 | 9 | 147 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 48 | 58 | 41 | 1 | 11 | 140 |
| Hodgkin disease | D006689 | — | C81 | 28 | 80 | 27 | 2 | 7 | 123 |
| Neoplasms | D009369 | — | C80 | 55 | 55 | 13 | 1 | 8 | 118 |
Show 25 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia | D007951 | — | C92 | 29 | 38 | 27 | — | 12 | 93 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 20 | 35 | 21 | — | 5 | 77 |
| Multiple myeloma | D009101 | — | C90.0 | 12 | 45 | 10 | — | 7 | 70 |
| Sarcoma | D012509 | — | — | 14 | 32 | 16 | — | 6 | 64 |
| Recurrence | D012008 | — | — | 24 | 35 | 7 | — | 5 | 61 |
| Myelodysplastic syndromes | D009190 | — | D46 | 22 | 26 | 13 | — | 3 | 55 |
| Plasma cell neoplasms | D054219 | — | — | 9 | 34 | 7 | — | 4 | 52 |
| Central nervous system neoplasms | D016543 | — | — | 10 | 28 | 7 | — | 5 | 49 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 13 | 27 | 8 | — | 2 | 44 |
| Follicular lymphoma | D008224 | — | C82 | 13 | 28 | 6 | — | 4 | 42 |
Show 119 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 8 | 18 | — | — | 6 | 29 |
| Plasmacytoma | D010954 | — | C90.3 | 5 | 13 | — | — | 2 | 20 |
| Hematologic neoplasms | D019337 | — | — | 8 | 7 | — | — | 3 | 17 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 6 | 10 | — | — | 4 | 17 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 6 | 4 | — | — | 3 | 12 |
| Adult t-cell leukemia-lymphoma | D015459 | — | C91.5 | 3 | 6 | — | — | 2 | 10 |
| Mycosis fungoides | D009182 | — | C84.0 | 5 | 4 | — | — | 2 | 10 |
| Lymphomatoid granulomatosis | D008230 | — | C83.8 | 4 | 4 | — | — | 3 | 9 |
| Aids-related lymphoma | D016483 | EFO_1001365 | — | 2 | 6 | — | — | 1 | 9 |
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 1 | 7 | — | — | 1 | 9 |
Show 135 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Large granular lymphocytic leukemia | D054066 | — | — | 2 | — | — | — | 2 | 4 |
| Neuroepithelial neoplasms | D018302 | — | — | 2 | — | — | — | — | 2 |
| Pharyngeal neoplasms | D010610 | — | C14.0 | 2 | — | — | — | — | 2 |
| Peritoneal neoplasms | D010534 | — | — | 2 | — | — | — | — | 2 |
| Melanoma | D008545 | — | — | 2 | — | — | — | — | 2 |
| Thymus neoplasms | D013953 | — | C37 | 1 | — | — | — | 1 | 2 |
| Esophageal neoplasms | D004938 | — | C15 | 1 | — | — | — | — | 1 |
| Urethral neoplasms | D014523 | EFO_0003846 | — | 1 | — | — | — | — | 1 |
| Esophageal squamous cell carcinoma | D000077277 | — | — | 1 | — | — | — | — | 1 |
| Mesothelioma | D008654 | — | C45 | 1 | — | — | — | — | 1 |
Show 13 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chediak-higashi syndrome | D002609 | Orphanet_167 | D72.0 | — | — | — | — | 2 | 2 |
| Hemoglobinuria | D006456 | — | R82.3 | — | — | — | — | 1 | 1 |
| Multiple primary neoplasms | D009378 | — | — | — | — | — | — | 1 | 1 |
| Ataxia | D001259 | — | R27.0 | — | — | — | — | 1 | 1 |
| Ataxia telangiectasia | D001260 | Orphanet_100 | G11.3 | — | — | — | — | 1 | 1 |
| Telangiectasis | D013684 | — | — | — | — | — | — | 1 | 1 |
| Cerebellar ataxia | D002524 | — | — | — | — | — | — | 1 | 1 |
| Peripheral blood stem cell transplantation | D036102 | — | — | — | — | — | — | 1 | 1 |
| Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
| Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | — | — | 1 | 1 |
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Etoposide phosphate |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
798 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use